Literature DB >> 28976835

Use of cryopreserved umbilical cord with negative pressure wound therapy for complex diabetic ulcers with osteomyelitis.

A Raphael1, J Gonzales2.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the combined use of cryopreserved human umbilical cord (cUC) allograft and negative pressure wound therapy (NPWT) in treating complex diabetic foot ulcers (DFUs) with bone exposure and osteomyelitis. These types of wound are known to carry a high morbidity and mortality.
METHODS: A single-center, retrospective chart review was performed to assess the efficacy of the combined use of cUC with NPWT, by the same surgeon, to help promote the closure of complex DFUs presenting with biopsy-proven osteomyelitis. Change in wound size and volume, time to wound closure, and number of cUC applications were assessed.
RESULTS: We identified of 14 wounds in 13 patients, with an average initial wound area of (mean±standard devaition) 33.2±21.7cm2 and wound volume of 52±26.2cm3. All achieved complete re-epithelialisation with an average time to closure of 24.0±10.9 weeks, using between 2-5 cUC applications. No adverse events were noted and none of the wounds required limb amputation during the a follow-up of 24 months for each patient.
CONCLUSION: The results suggest that combined use of cUC and NPWT may be effective in improving the healing of complex DFUs that present with osteomyelitis. Prospective, randomised controlled trials are warranted to confirm this efficacy as well as its potential applications in other chronic wounds.

Entities:  

Keywords:  NPWT; complex wounds; cryopreserved umbilical cord; diabetic foot ulcer; osteomyelitis

Mesh:

Year:  2017        PMID: 28976835     DOI: 10.12968/jowc.2017.26.Sup10.S38

Source DB:  PubMed          Journal:  J Wound Care        ISSN: 0969-0700            Impact factor:   2.072


  7 in total

1.  A randomized trial of negative pressure wound therapy technology combined with intermittent instillation in the treatment of neck anastomotic leakage after esophageal cancer surgery.

Authors:  Bao-Jia Luo; Hui-Qin Zhang; Jiu-Di Zhong; Xiang-Zi He; Fang Shen; Mei-Chun Zheng; Yong-Shan Wen; Jin-Bo Li; Ming-Zhu Xin
Journal:  J Gastrointest Oncol       Date:  2021-12

Review 2.  Umbilical cord tissue cryopreservation: a short review.

Authors:  Irina Arutyunyan; Timur Fatkhudinov; Gennady Sukhikh
Journal:  Stem Cell Res Ther       Date:  2018-09-15       Impact factor: 6.832

3.  Successful treatment of painful chronic wounds with amniotic and umbilical cord tissue: A case series.

Authors:  Pablo Acevedo
Journal:  SAGE Open Med Case Rep       Date:  2020-04-27

4.  Umbilical amnion and amniotic membrane transplantation for infectious scleritis and scleral melt: A case series.

Authors:  Zeba A Syed; Christopher J Rapuano
Journal:  Am J Ophthalmol Case Rep       Date:  2021-01-23

5.  Use of Cryopreserved Human Umbilical Cord for Wound Healing of the Nose after Mohs Micrographic Surgery.

Authors:  Kathleen Herne; Robert K Fabric
Journal:  Case Rep Dermatol Med       Date:  2022-03-08

6.  Use of Human Umbilical Cord and Its Byproducts in Tissue Regeneration.

Authors:  Francesca Velarde; Verónica Castañeda; Emilia Morales; Mayra Ortega; Edwin Ocaña; Jose Álvarez-Barreto; Michelle Grunauer; Luis Eguiguren; Andrés Caicedo
Journal:  Front Bioeng Biotechnol       Date:  2020-03-10

7.  An open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis.

Authors:  William A Marston; John C Lantis; Stephanie C Wu; Aksone Nouvong; Tommy D Lee; Nicholas D McCoy; Herbert B Slade; Scheffer C Tseng
Journal:  Wound Repair Regen       Date:  2019-08-19       Impact factor: 3.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.